Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAminex Regulatory News (AEX)

Share Price Information for Aminex (AEX)

Share Price is delayed by 15 minutes
Get Live Data
2.625    -0.05 (-1.85%)
Bid:
2.60
Ask:
2.65
Spread: 0.05 (1.923%)
Market Cap: £118.59m
AEX Live PriceLast checked at - London Stock Exchange

Intraday Aminex Share Chart

Placing and Open Offer

30 Jun 2009 07:00

RNS Number : 7342U
Aminex PLC
30 June 2009
Ā 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN PART OR IN WHOLE IN OR INTO THE UNITEDĀ STATES,Ā AUSTRALIA,Ā CANADA,Ā JAPANĀ ORĀ SOUTH AFRICAĀ OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

This announcement is an advertisement and not a prospectus and investors should not subscribe for or purchase any shares referred to in this announcement except on the basis of information inĀ theĀ ProspectusĀ inĀ connection with theĀ Placing andĀ Open OfferĀ to be published in due course (the "Prospectus").Ā Ā Copies of the Prospectus will, following publication, be available,Ā inter alia,Ā at www.aminex-plc.com.

30Ā JuneĀ 2009

Aminex PLC ("Aminex" or the "Company")

PlacingĀ to raise US$11.45Ā millionĀ andĀ proposedĀ Open OfferĀ toĀ raise up to US$3Ā millionĀ 

Highlights

Intention to place 116,330,998 new Ordinary Shares at Stg6p per share to raise Stg£6.98 million (approximately US$11.45 million) before expenses (the "Placing");

Intention to conduct a non-underwritten Open Offer to qualifying shareholders of up to 30,266,841 Ordinary Shares on the basis of 1 new Ordinary Share for every 8 existing Ordinary Shares held on a record date (to be determined) at Stg6p per share to raise up to Stg£1.82 million (approximately US$3 million) before expenses (the "Open Offer");

Proceeds of the intended Placing and Open Offer to fund Aminex's exploration and development programme;

The Placing and theĀ Open OfferĀ are conditional,Ā inter alia, upon shareholder approval to be sought at an extraordinary general meeting of the Company;

2007 warrants to be extended for 12 months to August 2010;Ā and

Appointment of Astaire SecuritiesĀ as the Company'sĀ LondonĀ broker.

Proposed Placing andĀ OPEN OFFER

The Board of Aminex is pleased to announce that Astaire Securities (as bookrunner) and Davy are arranging a Placing to raise gross proceeds of approximately StgĀ£6.98 million (approximately US$1.45 million) by way of a placing of 116,330,998 new Ordinary Shares of nominal value €0.06 each at a price of Stg6p each ("Placing Shares") with new and existing institutional investors. The Placing will represent approximately 47% of the existing issued share capital.

The Board also announces its intention to give Aminex shareholders an opportunity to participate in the fundraising by way of a 1 forĀ 8Ā Open OfferĀ of up toĀ 30,266,841Ā new Ordinary Shares of nominal value €0.06 each at a price of Stg6p each ("Open OfferĀ Shares") to raise up to an additionalĀ StgĀ£1.82m (approximatelyĀ US$3million). Participants in the Placing will not have an entitlement to participate in theĀ Open OfferĀ in respect of their Placing Shares. Shareholders will be able to apply under the Open Offer for shares in excess of their entitlements. To the extent that excess applications are received, such applications will be scaled backĀ pro rataĀ such that funds raised from the Open Offer will not exceedĀ StgĀ£1.82Ā million.Ā Ā Astaire Securities and Davy have reserved the right to place any unsubscribed Open Offer Shares for the benefit of the Company at the Placing Price of Stg6p, for a period of up toĀ 7Ā days following the closing date of the Open Offer.

Relative to the closing market price per Ordinary Share on the London Stock Exchange on 29 June 2009 (the last business date prior to this announcement) of Stg8p, the issue price under the Placing and the Open Offer represents a discount of approximately 25%.

The net proceeds of the Placing of approximately Stg£6.2 million (after estimated expenses) are intended to be used, in conjunction with the Company's existing cash resources, to facilitate Aminex's exploration and development programme and to supplement working capital.  The proceeds will primarily be used for exploration and appraisal activity in East Africa and in particular to finance the Company's share of the Mikindani-1 well which is scheduled to be drilled on the Company's Ruvuma licence in the third quarter of 2009 in partnership with Tullow Oil plc. The ultimate cost of this well to Aminex may be less than budgeted as the Company is in the process of seeking farm-in partners.  Net proceeds of the Open Offer are intended to be used to advance the Company's exploration and development programme in the USA and East Africa.

The implementation of the Placing, which is not underwritten, is conditional,Ā inter alia,Ā onĀ shareholder approval and on admissionĀ of the Placing Shares.Ā TheĀ Open Offer, which is not underwritten,Ā will beĀ conditional,Ā inter alia,Ā on shareholder approval andĀ upon the Placing having become unconditional in all respects.

PROSPECTUS, CIRCULAR AND GENERAL MEETING

An extraordinary general meeting will be held onĀ 12Ā noonĀ on 23 July 2009Ā atĀ The Charlotte Street Hotel,Ā Charlotte Street,Ā LondonĀ W1T 1RJ,Ā United KingdomĀ (the "EGM"). The purpose of the EGM is to consider and, if thought fit, to passĀ theĀ resolution necessary to authorise and carry out the Placing and Open Offer.

A circular containing a notice of extraordinary general meeting will be sent to Shareholders in due course. Shareholders should read the full text of theĀ resolution contained in the Notice of General Meeting in the Circular.Ā 

In connection with the Placing and Open Offer, the CompanyĀ will publish a Prospectus containingĀ full details, including the terms and conditions, of the Placing and Open Offer whichĀ will beĀ available toĀ Shareholders on the Company's websiteĀ (www.aminex-plc.com)Ā and at its registered office. It is anticipated that the Prospectus, subject to the approval of the Financial Regulator,Ā will be published on or aboutĀ 17Ā JulyĀ 2009.

Proposed extension of the 2007 Warrants exercise period

In conjunction with an equity placingĀ and rights issueĀ undertaken in May 2007, the Company granted warrants to investors on the basis of 1 warrant for every 2 Ordinary Shares subscribed for under theĀ funding. Each warrant entitles the holder to subscribe for 1 Ordinary Share at a price ofĀ StgĀ 22p each. The warrants are exercisable at anytime up to 31 August 2009.

As of the date of this announcement, there were approximately 36 .4 million warrants in issue and in the event that all such warrants were exercised, approximately Stg£8 million would be paid to the Company which could be used to advance the Company's exploration and development programme. Taking into consideration the current market price of the Company's ordinary shares, the Directors believe that it is unlikely that these warrants will be exercised prior to their expiry on 31 August 2009 and the potential proceeds will be forgone. Consequently the Directors intend to extend the exercise period of the warrants by an additional 12 months. The Directors believe that this would be in the best interest of the Company and the shareholders as a whole. The extension of the exercise period requires the approval of a special resolution of the warrant holders which will be proposed in due course.

Brian Hall,Ā ChairmanĀ commented:

"TheĀ oversubscribed placing being arranged by Astaire Securities and Davy will enable Aminex to move forward with itsĀ explorationĀ and developmentĀ programmes, commencing with the drilling of the first wellĀ in the RuvumaĀ Basin ofĀ TanzaniaĀ where a firstĀ well is scheduledĀ to beĀ spuddedĀ in theĀ next three months.Ā We are pleased to welcome Astaire Securities as ourĀ LondonĀ broker whichĀ will be working alongsideĀ Davy,Ā our existing Irish broker."

Further Information

The Placing, which is not underwritten, is being arranged byĀ Astaire Securities and Davy. The Placing is conditional, inter alia,Ā onĀ (i)Ā shareholder approval; (ii)Ā the PlacingĀ Agreement becoming unconditional in all respects as regards the Placing;Ā andĀ (iii)Ā admission of the Placing Shares to theĀ OfficialĀ Lists of the Irish Stock Exchange and the UK Listing Authority and to trading on the main markets for listed securities of the Irish Stock Exchange and the London Stock Exchange.Ā The Placing is not conditional upon theĀ Open Offer.Ā Ā TheĀ Open Offer, which is not underwritten, is conditional,Ā inter alia, uponĀ shareholder approval andĀ the Placing having become unconditional in all respects.Ā Ā Further announcements will be made by Aminex, including an announcement detailing the expected timetable in connection with the Open Offer, in due course.

For further information:

Aminex

Brian Hall, Chairman

Tel: +44 (0) 20 72913100

Davy

Ā 

EugenƩe Mulhern / Brian Garrahy

Tel: +353 (0) 1 6796363Ā 

Astaire Securities

Jerry Keen / Shane GallweyĀ 

Tel: + 44 (0)Ā 20 7448 4492

Pelham Public Relations

Archie Berens

Tel: +44 (0) 20 7337 1509

J&E Davy (collectively ''Davy'') (each of which is regulated in Ireland by the Irish Financial Services Regulatory Authority) andĀ Astaire SecuritiesĀ plcĀ (''Astaire Securities") (which is regulated in the UK by the Financial Services Authority) are acting exclusively for Aminex in connection with the requirements of the Irish Stock Exchange and the UK Listing Authority and for no one else and will not be responsible to any other person for providing the protection afforded to customers ofĀ Astaire Securities orĀ DavyĀ respectivelyĀ nor for providing advice in connection with this announcement.

Participation in the proposedĀ Open OfferĀ will not be available to shareholders resident in theĀ United States,Ā Australia,Ā Canada,Ā South AfricaĀ orĀ JapanĀ or any other jurisdiction where it would be unlawful to offer participation.

This announcement does not constitute, or form part of, an offer of, or the solicitation of any offer to subscribe for or buy, any of the Ordinary Shares to be issued or sold in connection with the Placing and/orĀ Open Offer.Ā Investors should not subscribe for or purchase any securities referred to in this announcementĀ except on the basis of information in the Prospectus to be published by the Company in due course in connection with the Placing andĀ Open Offer.

The offer of the Ordinary Shares in certain jurisdictions may be restricted by law and therefore potential investors should inform themselves about and observe any such restrictions. This announcement is not for publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, South Africa or any other jurisdiction in which such publication or distribution would be a violation of the relevant laws of such jurisdiction. This announcement is for information only and does not constitute an offer or invitation to acquire or dispose of Ordinary Shares in the United States, Australia, Canada, Japan, South Africa or any other jurisdiction in which such offer or invitation would be a violation of the relevant laws of such jurisdiction. In particular, the Placing and Open Offer will not be an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offering of Ordinary Shares in Aminex in the United States. The Ordinary Shares have not been and will not be registered under the US Securities Act of 1933, as amended ('the Securities Act'), or with any securities regulatory authority of any state or other jurisdiction of the United States, and may not be offered or sold in the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.Ā 

Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser.

The distribution of this announcement may be restricted by law. No action has been taken that would permit the possession or distribution of this announcement in any jurisdiction where action for that purpose is required.

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
IOECKCKQCBKDCAB
Date   Source Headline
1st Jun 20269:49 amRNSTotal Voting Rights
11th May 20264:07 pmRNSDirector/PDMR Shareholding
11th May 20264:02 pmRNSExercise of Options and Total Voting Rights
30th Apr 20265:29 pmRNSDirector/PDMR Shareholding
28th Apr 20269:11 amRNSFinal Results and Annual Report 2025
12th Mar 20264:43 pmRNSHolding in Company
12th Mar 20264:40 pmRNSPerson Closely Associated Dealing
27th Feb 202612:11 pmRNSExercise of Options and Total Voting Rights
3rd Feb 20261:45 pmRNSNtorya Operations Update
23rd Jan 20267:00 amRNSNtorya to Madimba Pipeline
18th Dec 20257:00 amRNSNtorya Operations Update
31st Oct 20257:00 amRNSTotal Voting Rights
6th Oct 20257:00 amRNSStrategic Placing to fund Aminex to Ntorya Revenue
26th Sep 20257:00 amRNS2025 Half-Yearly Financial Report
27th Aug 20257:00 amRNSNtorya Operations Update
24th Jul 20254:03 pmRNSResult of AGM
17th Jul 202512:00 pmRNSNtorya Operations Update
3rd Jul 20253:15 pmRNSNtorya to Madimba Pipeline Contract Awarded
30th Jun 202511:31 amRNSNotice of AGM
30th Apr 20254:21 pmRNS2024 Annual Report and Accounts
29th Apr 20254:53 pmRNSFinal Results and Annual Report 2024
5th Mar 20257:00 amRNSNtorya Operations Update
30th Sep 20247:00 amRNS2024 Half-Yearly Financial Report
11th Sep 20242:27 pmRNSNtorya Development Licence handover ceremony
27th Jun 202412:55 pmRNSResult of AGM
19th Jun 20243:02 pmRNSDirector/PDMR Dealing
19th Jun 20242:31 pmRNSExercise of Options and Total Voting Rights
3rd Jun 20247:00 amRNSNotice of AGM
23rd May 20244:04 pmRNSNtorya Development Licence Granted
10th May 20247:00 amRNSUpdate on Ntorya to Madimba Pipeline
29th Apr 20247:01 amRNSFinal Results and Annual Report 2023
29th Apr 20247:00 amRNSFunding Facility agreed with Eclipse Investments
29th Feb 20247:00 amRNSRuvuma Seismic Update
10th Jan 20242:49 pmRNSRuvuma Gas Sales Agreement signed
31st Oct 20235:00 pmRNSKiliwani Operations Update
29th Sep 20237:00 amRNS2023 Half-Yearly Financial Report
1st Sep 20237:00 amRNSDirectorate Change
13th Jul 20234:26 pmRNSResult of AGM
12th Jul 20237:00 amRNSRuvuma Operations Update
20th Jun 20237:00 amRNSNotice of AGM
2nd Jun 20233:13 pmRNSDirector/PDMR Shareholding
26th May 20237:00 amRNSPublication of New Research
28th Apr 20236:13 pmRNSFinal Results and Annual Report 2022
2nd Mar 20237:00 amRNSStrategy/Company/Ops Update
6th Feb 202311:05 amRNSSecond Price Monitoring Extn
6th Feb 202311:00 amRNSPrice Monitoring Extension
6th Feb 20239:05 amRNSSecond Price Monitoring Extn
6th Feb 20239:00 amRNSPrice Monitoring Extension
28th Nov 202211:05 amRNSSecond Price Monitoring Extn
28th Nov 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.